Raloxifene (HCl)
Raloxifene (HCl) is a nonsteroidal antioestrogen with some oestrogenic activity. Raloxifene (HCl) is used in women who are at great risk of post-menopausal osteoporosis. Raloxifene (HCl) is also indicated for prophylaxis and treatment of vertebral fractures in postmenopausal women.
Primary Characteristics
Raloxifene (HCl) is also known as Raloxifene.
It belongs to Benzothiophene.
It belongs to Oestrogen Agonist pharmacological group on the basis of mechanism of action and also classified in Hormones pharmacological group. It is also classified under Hormones .
Molecular Weight: 510 · Solubility in Water: very slightly · Solubility in Alcohol: null · Non-proprietary name: Raloxifene (HCl).

Pharmacokinetics
Absorption: Raloxifene (HCl) has an oral bioavailability is 30% (±30%).
Distribution: Raloxifene (HCl) has a volume of distribution is 2348 l/kg. plasma protein binding is >95%.
Elimination: plasma half-life is 27 hr, renal excretion is < 6 %.
Advertisement
Indications
Raloxifene (HCl) is primarily indicated in conditions like Prevention of osteoporosis, Sedation with amnesia.
Raloxifene (HCl) is also indicated for secondary conditions like Postmenopausal disorders.
Contraindications
Raloxifene (HCl) is contraindicated in conditions like Thrombosis, Vaginal bleeding.
Dosage
Raloxifene (HCl)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 60 mg | 60 mg | Every 24h | PO | |
| Paediatric Dosage (20kg) | ||||
| 0 – 0 | — | — | Not applicable in paeds | |
| Neonatal Dosage (3kg) | ||||
| No data. | ||||
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Raloxifene (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Depression, Fever, Flatulence, Gastroenteritis , Hot flushes, Increased intracranial pressure, Insomnia, Migraine , Nausea, Rashes , Vomiting , Weight gain.
Warnings / Precautions
Available Brands
Storage Conditions
Drug Classification
- 1.18.4 — Estrogens, their combinations and related preparations
- 2.18.14 — Drugs affecting bone metabolism